We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Instrumentarium to Divest Cardiology Monitoring Unit

By HospiMedica staff writers
Posted on 13 Jan 2003
An agreement to sell the cardiology business subsidiary of its Spacelabs Medical division for US$ 24 million to Quinton Cardiology Systems, Inc. (Bothell, WA, USA) has been announced by Instrumentarium (Helsinki, Finland). The cardiology subsidiary is Burdick, Inc. (Deerfield, WI, USA).

Burdick is a supplier of electrocardiogram (ECG) cardiographs, Holter monitors, stress testing systems, and cardiology information systems. The company had net sales of about $38 million in 2001. Quinton is a provider of cardiac stress testing systems, cardiac rehabilitation equipment, Holter monitoring devices, and ECG management systems. Quinton's 2001 sales were $42.9 million.

As part of the transaction, Quinton and Spacelabs Medical have entered into a cooperative sales and marketing agreement for certain products as well as an agreement to cross-license certain intellectual property related to ECG technologies and systems. Instrumentarium acquired Spacelabs Medical in July 2002, in a move to strengthen its presence in the critical care patient-monitoring market.





Related Links:
Instrumentarium
Quinton
SpaceLabs

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Medical Magnifier
EX-06
New
Surgical Operating Lamp
OKM 600E

Latest Business News

Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights

Arab Health 2025 Celebrates Landmark 50th Edition

Boston Scientific Acquires Medical Device Company Intera Oncology